Shalini Kaul Mahesh Uparkar Kruti Mody Jaydeep Walinjkar Mihir Kothari S Natarajan
10.4103/0301-4738.58480
Indian J Ophthalmol
2010 Jan-Feb;58(1):76-8.
CC BY
https://pubmed.ncbi.nlm.nih.gov/20029154/
Angiogenesis Inhibitors / administration & dosage Antibodies, Monoclonal / administration & dosage Aptamers, Nucleotide / administration & dosage Retinal Diseases / drug therapy Retinal Vessels / pathology Telangiectasis / drug therapy Vascular Endothelial Growth Factor A / antagonists & inhibitors
Angiogenesis Inhibitors / administration & dosage Antibodies, Monoclonal / administration & dosage Aptamers, Nucleotide / administration & dosage Retinal Diseases / drug therapy Retinal Vessels / pathology Telangiectasis / drug therapy Vascular Endothelial Growth Factor A / antagonists & inhibitors Case Reports Adolescent Antibodies, Monoclonal, Humanized Bevacizumab Child Child, Preschool Diagnosis, Differential Drainage Female Humans Injections Laser Coagulation Male Retinal Diseases / diagnosis Retinal Diseases / surgery Telangiectasis / diagnosis Telangiectasis / surgery Tomography, Optical Coherence Tomography, X-Ray Computed Vitreous Body Angiogenesis Inhibitors Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Aptamers, Nucleotide Vascular Endothelial Growth Factor A pegaptanib Bevacizumab
PMC2841382
20029154
Intravitreal anti-vascular endothelial growth factor agents as an adjunct in the management of Coats' disease in children
2010